Estriol (E3)

Class Steroid hormone (estrogen)Receptor Estrogen receptors ERα/ESR1 and ERβ/ESR2

Function

Estriol is an estrogen hormone primarily associated with pregnancy physiology, placental endocrine activity, fetal-maternal communication, and reproductive tissue adaptation. It is considered a weaker estrogen compared with estradiol but becomes highly significant during pregnancy due to large increases in circulating levels. Estriol contributes to uterine growth, vascular adaptation, placental signaling, cervical remodeling, and preparation of maternal tissues for gestation and childbirth.

The hormone also influences blood flow regulation, connective tissue remodeling, immune communication during pregnancy, and endocrine coordination between fetal and maternal systems. Estriol participates in maintenance of uteroplacental circulation and supports physiological adaptation to increasing fetal metabolic demand.

Production

Estriol is produced mainly during pregnancy through coordinated interaction between fetal adrenal glands, fetal liver, placenta, and maternal tissues. Fetal adrenal glands produce dehydroepiandrosterone sulfate, which is modified by fetal liver pathways and converted by placental steroidogenic enzymes into estriol.

Because fetal and placental tissues cooperate in synthesis, estriol production reflects integrated fetal-maternal endocrine physiology. Small nonpregnancy amounts may be produced through peripheral estrogen metabolism, but pregnancy-associated production accounts for the majority of circulating estriol. Placental aromatase and sulfation pathways are central to this process.

Regulation

Estriol production is regulated primarily by placental function, fetal adrenal steroid production, uteroplacental blood flow, maternal endocrine environment, and fetal liver metabolic activity. The hormone increases progressively during pregnancy as fetal growth and placental endocrine activity expand.

Estriol acts through estrogen receptor pathways within reproductive tissues, vascular structures, connective tissue, and immune-regulating systems. Hormonal interactions involving progesterone, placental growth factors, and maternal cardiovascular adaptation influence overall physiological effects. Regulation of estriol therefore reflects coordinated endocrine communication between placenta, fetus, and maternal tissues during pregnancy-related metabolic and structural adaptation.

Identity & Secretion

Primary Source GlandPlacenta (fetoplacental unit during pregnancy); peripheral tissues (adipose/skin/brain) at low levels otherwise
Secretion PatternPregnancy-associated elevations with diurnal/circadian variation; low outside pregnancy with peripheral production.
Precursor16α-hydroxy-DHEA-S → 16α-hydroxy-androstenedione → Estriol via aromatase (CYP19A1); Estrone/Estradiol may interconvert peripherally

Nutrient Requirements

Nutrient Precursors
  • Endogenous cholesterol provides steroid backbone; adequate amino acids support enzyme synthesis.
Required Vitamins
  • B3 (NADPH pools), B2 (FAD redox), B5 (CoA) — contextual cofactor support for steroidogenic/P450 enzymes.
Required Minerals
  • Iron (heme for P450s), Zinc, Magnesium — contextual enzyme/cofactor roles.

Key Foods

  • Whole-food plant patterns (legumes/soyfoods, flaxseed, whole grains, vegetables, fruits, nuts/seeds) align with metabolic and microbiome contexts studied with estrogen physiology (observational).

Targets & Signaling

Target Tissues
  • Uterus, breast, bone, liver, adipose, vascular endothelium, brain, hypothalamus/pituitary
Feedback Loops
  • Negative feedback on GnRH/LH/FSH depends on life stage and overall estrogen milieu; SHBG modulates free fraction.
Second Messengers
  • Genomic via ERs; rapid non-genomic ER/GPER1 signaling can engage PI3K/MAPK/cAMP in some cells.
Pathways Involved
  • Aromatase pathway (CYP19A1); ER genomic programs; HSD17B interconversions; enterohepatic cycling; peripheral intracrine estrogen formation.

Key Functions

  • Supports estrogen-responsive tissue programs (gestational context predominates); contributes to bone and vascular signaling via ERs.

Plant-Based Focus

  • Plant-forward, fiber-rich diets with diverse polyphenols are studied in relation to estrogen metabolism, enterohepatic cycling, and metabolic health (informational).

Clinical Context

Assay Notes
Interpret by life stage (pregnancy vs non-pregnancy), specimen (serum/urine), time-of-day, SHBG, and assay method; LC-MS/MS preferred for specificity.

Linked Knowledge

Phytochemicals
  • Genistein, daidzein, resveratrol, quercetin (studied for ER/aromatase interactions in experimental systems; informational only).
Foods
  • Soyfoods/legumes, flaxseed, whole grains, vegetables, fruits, nuts/seeds (dietary patterns associated with metabolic/bone health).
Vitamins
  • B-vitamins from whole grains/legumes/greens (contextual enzyme cofactor supply).
Minerals
  • Iron, zinc, magnesium (contextual enzyme/cofactor roles).
Cancers (context)
  • Estrogen signaling discussed in breast/endometrial cancer biology (context only, non-diagnostic).
Ailments
  • Contextual: life-stage physiology (pregnancy), bone and vascular discussions in literature (non-diagnostic here).

Dietary Modulators

  • High-fiber intake, diverse plant polyphenols, circadian-aligned meals, and regular activity are associated with favorable metabolic/microbiome contexts.

Inhibitors / Activators

Inhibitors
  • Experimental aromatase inhibitors (drug class; not dietary). Certain polyphenols may inhibit aromatase in vitro (informational only).
Activators
  • FSH/placental signals drive aromatase expression; healthy sleep–light cycles and energy balance support endocrine rhythms.

Summary

Estriol is a physiologic estrogen most abundant in pregnancy, acting via ERs to support reproductive, skeletal, metabolic, and vascular programs.

SUMMARY OF EFFECTS ON THE BODY

Contributes to estrogenic support of uterine/vascular function and bone maintenance; life-stage dependent.

Research

Aromatase and HSD17B mechanisms; ERα/ERβ and GPER1 signaling; fetoplacental biosynthesis during pregnancy.
Created: Nov 11, 2025 Updated: May 27, 2026